Pharmadrug(OTC) LMLLF

Current Price$0.01

Market Cap$691.20K

Since IPO (2018)-100%

5 Year-98%

1 Year-42%

1 Month+91%

Pharmadrug last closing stock price
Metric	Price	Date
Last close	USD 0.01	2026-07-24

Pharmadrug stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-3.92%	USD 0.01	2026-07-17
1 month	+90.74%	USD 0.00	2026-06-24
3 month	-52.31%	USD 0.01	2026-04-22
Year to date	-42.13%	USD 0.01	2025-12-31
1 year	-41.81%	USD 0.01	2025-07-24
3 year	-86.25%	USD 0.04	2023-07-25
5 year	-98.37%	USD 0.32	2021-07-23
Since inception	-99.76%	USD 2.15	2018-08-30

Pharmadrug Financials at a Glance

Market Cap

$691.20K

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$470.38K

EPS (TTM)

-$0.00

P/E Ratio

-1.78

Dividend

$0.00

Beta (Volatility)

-0.75 (Low)

Dividend

$0.00

Beta (Volatility)

-0.75 (Low)

Price

$0.01

Volume

Open

$0.01

Price

$0.01

Volume

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

May 21, 2026

Dividend

$0.00

Beta (Volatility)

-0.75 (Low)

Price

$0.01

Volume

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

May 21, 2026

LMLLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pharmadrug

Pharmadrug Inc. is a specialized pharmaceutical company focused on the exploration, development, and commercialization of controlled substances and naturally derived therapeutic agents. The company is actively involved in importing and distributing medical cannabis across Germany and the European Union, while also researching innovative compounds like psychedelics and cannabis.

Products and Services

Development of novel compounds, including psychedelics and cannabis
Import and distribution of medical cannabis to pharmacies
Research initiatives on functional and psilocybin mushrooms

Growth Outlook

Partnership with the University of Michigan to study DMT's effects
Clinical trial agreement with Johns Hopkins University for DMT research
Expansion of medical cannabis distribution in the European market

Financial Highlights

Recent quarterly net income of -$187,222, reflecting ongoing investment in R&D
Trailing twelve months (TTM) revenue remains at $0, indicating a focus on future growth
Cash and short-term investments totaled $388,709 as of March 31, 2026

AI Generated • Jun 30, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Robert J. Steen, MBA

Website

www.pharmadrug.co

Headquarters

Toronto, ON M5K 1H1, CA

LMLLF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

28.90%

Return on Capital

N/A

Return on Assets

-51.77%

Earnings Yield

-56.18%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$691.20K

Shares Outstanding

134.21M

Volume

Avg. Volume

21.72K

Financials (TTM)

Gross Profit

-CA$46.95K

Operating Income

-CA$200.51K

EBITDA

-CA$173.12K

Operating Cash Flow

-CA$64.08K

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$64.08K

Cash & ST Invst.

CA$388.71K

Total Debt

CA$1.61M

Pharmadrug Performance Analysis

Pharmadrug annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	CAD 0	N/A
2023	2023-12-31	CAD 0	N/A
2024	2024-12-31	CAD 0	N/A
2025	2025-12-31	CAD 0	N/A

Pharmadrug sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	N/A
Q3	2025-09-30	N/A
Q4	2025-12-31	N/A
Q1	2026-03-31	N/A

Pharmadrug annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	CAD -0.10	6.7%
2023	2023-12-31	CAD -0.17	71.0%
2024	2024-12-31	CAD -0.01	-96.8%
2025	2025-12-31	CAD -0.00	-55.4%

Pharmadrug sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	22.2%
Q3	2025-09-30	-42.9%
Q4	2025-12-31	N/A
Q1	2026-03-31	-40.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$12.59K

-44.3%

Gross Margin

0.00%

N/A

Market Cap

$691.20K

N/A

Market Cap/Employee

$76.80K

N/A

Employees

N/A

Net Income

-CA$187.22K

-87.0%

EBITDA

-CA$34.51K

+33.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

CA$388.71K

+419.9%

Total Debt

CA$1.61M

+17.0%

Accounts Receivable

CA$18.38K

+100.6%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$1.61M

+17.0%

Return on Assets

-51.77%

N/A

Return on Invested Capital

19.10%

N/A

Free Cash Flow

-CA$64.19K

-430934.7%

Operating Cash Flow

-CA$64.19K

-430928.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

UBQUUbiquitech Software Corp.

UBQUUbiquitech Software Corp.$0.00+0.00%

RDDTFRadient Technologies Inc.

RDDTFRadient Technologies Inc.$0.00+0.00%

CPMDCannaPharmaRX, Inc.

CPMDCannaPharmaRX, Inc.$0.00+0.00%

TGIFF1933 Industries Inc.

TGIFF1933 Industries Inc.$0.00+1.18%

CNGGFCann Group Limited

CNGGFCann Group Limited$0.00+0.00%

RAFARafarma Pharmaceuticals, Inc.

RAFARafarma Pharmaceuticals, Inc.$0.03-20.00%

RVVTFRevive Therapeutics Ltd.

RVVTFRevive Therapeutics Ltd.$0.02-7.69%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$92.32-0.08%

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

Questions About LMLLF

What is the current price of Pharmadrug?

Pharmadrug is trading at $0.01 per share.

What is the 52-week range for Pharmadrug?

Over the past 52 weeks, Pharmadrug has traded between $0.00 and $0.02.

How much debt does Pharmadrug have?

As of the most recent reporting period, Pharmadrug reported total debt of CA$1.15M.

How much cash does Pharmadrug have on hand?

Pharmadrug reported CA$38.75K in cash and cash equivalents in its most recent financial results.

What is Pharmadrug’s dividend yield?

Pharmadrug does not currently have a dividend yield.

Pharmadrug(OTC) LMLLF

Pharmadrug Financials at a Glance

LMLLF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Pharmadrug

LMLLF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Pharmadrug Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LMLLF

What is the current price of Pharmadrug?

What is the 52-week range for Pharmadrug?

How much debt does Pharmadrug have?

How much cash does Pharmadrug have on hand?

What is Pharmadrug’s dividend yield?

Premium Investing Services